Showing 4,321 - 4,340 results of 18,392 for search 'significant ((((a decrease) OR (((we decrease) OR (nn decrease))))) OR (mean decrease))', query time: 0.52s Refine Results
  1. 4321

    Table 7_Epizootic shell disease induces systemic transcriptomic shifts in Homarus americanus, characterized by increased shell degradation and impaired energy metabolism across tis... by Minseo Kim (773205)

    Published 2025
    “…In a previous study, we found that the microbiome composition of the carapace in lobsters with ESD differed from that of healthy individuals, with ESD-associated bacteria enriched in the green gland and testis. …”
  2. 4322

    Table 5_Epizootic shell disease induces systemic transcriptomic shifts in Homarus americanus, characterized by increased shell degradation and impaired energy metabolism across tis... by Minseo Kim (773205)

    Published 2025
    “…In a previous study, we found that the microbiome composition of the carapace in lobsters with ESD differed from that of healthy individuals, with ESD-associated bacteria enriched in the green gland and testis. …”
  3. 4323

    Loxoprofen or SB225002 administration attenuated inflammatory pain in complete Freund’s adjuvant (CFA)-injected mice exposed to sound stress. by Satoka Kasai (3861115)

    Published 2025
    “…<b>(A)</b> Loxoprofen administration (500 mg/kg) significantly decreased the response times to filament in CFA + saline group 60 min after administration (***<i>P</i> < 0.001), and in CFA + stress + saline group (30 and 60 min after administration, **<i>P</i> < 0.01). …”
  4. 4324
  5. 4325
  6. 4326
  7. 4327
  8. 4328
  9. 4329
  10. 4330
  11. 4331

    Valve closing capability and hemolymph flow analysis. by Christian Meyer (6035)

    Published 2025
    “…(J) Analysis of hemolymph flow in the aorta. Mean pixel intensity of the dye package is significantly reduced upon valve malformation, indicating less hemolymph is pumped (Scheme illustrates dye package in the aorta and its area analyzed). …”
  12. 4332
  13. 4333

    Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer by Jiaxing Li (113609)

    Published 2025
    “…Herein, we reported an effective and selective PRMT7 inhibitor, <b>A33</b>, which was obtained through structural optimization and exhibited potent anti-PCa efficacy in vitro and in vivo. …”
  14. 4334

    Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer by Jiaxing Li (113609)

    Published 2025
    “…Herein, we reported an effective and selective PRMT7 inhibitor, <b>A33</b>, which was obtained through structural optimization and exhibited potent anti-PCa efficacy in vitro and in vivo. …”
  15. 4335

    Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer by Jiaxing Li (113609)

    Published 2025
    “…Herein, we reported an effective and selective PRMT7 inhibitor, <b>A33</b>, which was obtained through structural optimization and exhibited potent anti-PCa efficacy in vitro and in vivo. …”
  16. 4336

    Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer by Jiaxing Li (113609)

    Published 2025
    “…Herein, we reported an effective and selective PRMT7 inhibitor, <b>A33</b>, which was obtained through structural optimization and exhibited potent anti-PCa efficacy in vitro and in vivo. …”
  17. 4337
  18. 4338
  19. 4339

    Effectiveness of abdominal bracing core exercises as rehabilitation therapy for reducing abdominal symptoms in patients with autosomal dominant polycystic kidney disease and signif... by Jaeyeong Yoo (17292907)

    Published 2025
    “…The purpose of this study was to assess the effectiveness of ABC rehabilitation exercises in reducing pain in ADPKD patients with significant PLD. Significant PLD was defined as a height-adjusted total liver volume (htTLV) exceeding 1,600 mL/m. …”
  20. 4340

    Table 1_Functional characterization of endocytic signals in the SynDIG/PRRT family members SynDIG1 and SynDIG4 in heterologous cells and neurons.xlsx by David J. Speca (20601326)

    Published 2025
    “…<p>The transmembrane protein Synapse Differentiation Induced Gene 4 (SynDIG4), also known as Proline-rich transmembrane protein 1 (PRRT1), is an AMPA-type glutamate receptor (AMPAR) auxiliary factor that is necessary for maintaining extra-synaptic pools of GluA1. Loss of SynDIG4, and the subsequent decrease in extra-synaptic GluA1, has been found to significantly impact synaptic plasticity in the hippocampus. …”